Related Experiment Videos
The pathogenesis of chronic myeloproliferative diseases
1Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. tefferi.ayalew@mayo.edu
Insights
This review explores the pathogenesis of chronic myeloproliferative disorders, including essential thrombocythemia and polycythemia vera. While clonal hematopoiesis is common, the specific molecular causes remain unclear.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chronic myeloproliferative disorders (MPNs) encompass essential thrombocythemia, polycythemia vera, and agnogenic myeloid metaplasia.
- Clonal hematopoiesis affecting all myeloid lineages is a hallmark of MPNs.
- The molecular drivers of MPN initiation and progression are not fully understood.
Purpose of the Study:
- To review current and past observations on the pathogenesis of MPNs.
- To highlight ongoing research into the molecular mechanisms underlying MPNs.
Main Methods:
- Literature review of existing research on MPN pathogenesis.
- Discussion of key molecular and cellular factors implicated in MPN development.
Main Results:
- Clonal hematopoiesis is a consistent feature across MPNs.
- The precise molecular lesions initiating and driving MPN progression are still under investigation.
- Cytokines, bone marrow microenvironment, and intracellular signaling pathways are areas of active research.
Conclusions:
- Understanding the molecular pathogenesis of MPNs is crucial for developing targeted therapies.
- Further research is needed to elucidate the complex interplay of factors contributing to MPN development.
Abstract:
Chronic myeloproliferative disorders are operationally classified to include essential thrombocythemia, polycythemia vera, and agnogenic myeloid metaplasia. In most cases, clonal hematopoiesis, involving all 3 myeloid lineages, can be demonstrated. However, the underlying molecular lesions that are responsible for disease initiation and progression remain elusive. There are ongoing efforts to clarify the pathogenetic role of cytokines, bone marrow stromal cells and molecules, and intracellular aberrations in either signal transduction or apoptosis. This review discusses some of the current and past observations regarding the pathogenesis of chronic myeloproliferative disorders.